MCM
NVAX icon

MAI Capital Management’s Novavax NVAX Stock Holding History

MAI Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-246
Closed -$2K – 3817
2026
Q1 		$2K Buy
246
+33
+15% +$299 ﹤0.01% 3925
2025
Q4 		$1.43K Sell
213
-1,562
-88% -$11.8K ﹤0.01% 3522
2025
Q3 		$15.4K Sell
1,775
-74
-4% -$576 ﹤0.01% 2530
2025
Q2 		$11.6K Buy
1,849
+26
+1% +$172 ﹤0.01% 2641
2025
Q1 		$11.7K Buy
1,823
+20
+1% +$165 ﹤0.01% 2421
2024
Q4 		$14.5K Buy
+1,803
New +$17.4K ﹤0.01% 2358
2020
Q3 		– Sell
-2,547
Closed -$212K – 610
2020
Q2 		$212K Buy
+2,547
New +$97.4K 0.01% 505

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

MAI Capital Management's NVAX Position: Q2 2026 in Review

MAI Capital Management sold out of Novavax (NVAX) in Q2 2026, closing a stake of 246 shares — an estimated $2K sold.

MAI Capital Management first reported a position in NVAX in Q2 2020 and held it in 7 quarters. The position peaked at $212K in Q2 2020. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • MAI Capital Management reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 246 Novavax shares in Q2 2026, an estimated $2K.
  • MAI Capital Management first reported a position in Novavax in Q2 2020 and held it in 7 quarters.
  • MAI Capital Management's Novavax position peaked at $212K in Q2 2020.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.